Modulation of cellular transport characteristics of the human lung alveolar epithelia

Jaleh Barar; Ali Maleki; Yadollah Omidi

doi:10.22037/ijpr.2010.671

IJ Pharmaceutical Research

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/ijpr.2010.671

Modulation of cellular transport characteristics of the human lung alveolar epithelia

Author(s):

Jaleh Barar^{1, 2,*},

Ali Maleki^{1, 2},

Yadollah Omidi^{1, 2}

1Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

2Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

IJ Pharmaceutical Research:Vol. 5, issue 3; 163-171

Published online:Nov 20, 2010

Article type:Research Article

Received:Jun 21, 2005

Accepted:Dec 21, 2005

How to Cite:Jaleh BararAli MalekiYadollah OmidiModulation of cellular transport characteristics of the human lung alveolar epithelia.Iran J Pharm Res.5(3):e128281.https://doi.org/10.22037/ijpr.2010.671.

Abstract

Among the drug delivery and targeting (DDT) routes, lung alveolar epithelium has been given enormous attentions in terms of the delivery of a wide range of macromolecules such as gene- or protein-based nanopharmaceuticals. However, little is known about cellular modulation of lung transport characteristics by endogenous and/or exogenous agents. Thus, in the current study, impact of dexamethasone (DEX), which is a customary additive to the culture media of alveolar epithelial cells, was assessed with respect to some transport properties of the human adenocarcinoma A549 cells, which is a well-known cell-based in vitro model for lung epithelia. To achieve such goal, we studied the trans epithelial electrical resistance (TEER) and barrier restrictiveness using the paracellular marker, mannitol. Further more, the effect of DEX on the expression of clathrin, the main integral protein of clathrin coated pits, as well as dynamin (GTP binding protein essential for the vesicle budding off process) were assessed. A549 cells treated with DEX displayed distinct phenotypic and growth changes, also resuling in higher TEER values (~ 100 Ω.cm²) compared to the untreated cells (~ 45 Ω.cm²). Such paracellular tightness properties were also confirmed by mannitol permeability assay, showing a marked difference in the permeability coefficient between untreated and DEX-treated A549 cells, i.e., 7.83± 0.3.7 (× 10^-6 cm.s^-1) and 3.46 ± 0.22 (× 10^-6 cm.s^-1), respectively. Although DEX exerted little impact on expression of the clathrin mRNA, it elicited a significant increase in dynamin protein expression. Therefore, it is proposed that DEX supplementation of alveolar epithelial A549 cells culture media may confer a better model for pulmonary DDT investigations. However, more extensive work is needed to be carried out in order to clarify the precise role of DEX in cellular transport of macromolecules via receptor-mediated endocytosis/transcytosis.

Keywords

Nanopharmaceutical targeting

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Jaleh Barar:[PubMed][Scholar]
Ali Maleki:[PubMed][Scholar]
Yadollah Omidi:[PubMed][Scholar]